Showing results (61-70 of 74) with videos related to

Sort By:
Pageof 8
Journal of the National Cancer Institute|April 5, 2017
A Plasma Biomarker Panel to Identify Surgically Resectable Early-Stage Pancreatic CancerSeetharaman Balasenthil, Ying Huang, Suyu Liu, et al.
Scientific Reports|November 14, 2022
Tumor suppressor DEAR1 regulates mammary epithelial cell fate and predicts early onset and metastasis in triple negative breast cancerUyen Q Le, Nanyue Chen, Seetharaman Balasenthil, et al.
Cancer Prevention Research (Philadelphia, Pa.)|April 24, 2021
Plasma miRNA Biomarkers in Limited Volume Samples for Detection of Early-stage Pancreatic CancerRachel L Dittmar, Suyu Liu, Mei Chee Tai, et al.
JMIR Medical Informatics|June 17, 2021
Hyperpolarized Magnetic Resonance and Artificial Intelligence: Frontiers of Imaging in Pancreatic CancerJosé S Enriquez, Yan Chu, Shivanand Pudakalakatti, et al.
Proceedings of the National Academy of Sciences of the United States of America|September 28, 2011
Maintenance of adenomatous polyposis coli (APC)-mutant colorectal cancer is dependent on Wnt/beta-catenin signalingAlix Scholer-Dahirel, Michael R Schlabach, Alice Loo, et al.
Oncogene|December 5, 1996
An 80 Kb P1 clone from chromosome 3p21.3 suppresses tumor growth in vivoM C Todd, R H Xiang, D K Garcia, et al.
Molecular Oncology|February 19, 2013
VGLL3 expression is associated with a tumor suppressor phenotype in epithelial ovarian cancerKaren Gambaro, Michael C J Quinn, Paulina M Wojnarowicz, et al.
Cancer Discovery|July 11, 2013
DEAR1 is a chromosome 1p35 tumor suppressor and master regulator of TGF-β-driven epithelial-mesenchymal transitionNanyue Chen, Seetharaman Balasenthil, Jacquelyn Reuther, et al.
Pageof 8